CANN AMERICAN (CNNA) Stock Price, News & Analysis
What Changed
Price Move History
- Daily moves over 5%
- 81 132 sessions, October 23, 2025 to October 26, 2026
- Largest daily move
- +2000% close of December 5, 2025
- 1-year change
- +92% closing prices, October 23, 2025 to October 26, 2026
- 1-month change
- -15.8% closing prices, September 25, 2026 to October 26, 2026
Company Description
CANN AMERICAN (OTC: CNNA) is classified in the drug manufacturers - specialty & generic industry within the Healthcare sector and carries a market capitalization of $1.6M.
CNNA has gained 92.0% over the past year. The last closing price was $0.0048.
For FY2012, CANN AMERICAN reported net income of -$1.7M and diluted earnings per share of $1000000.00.
This page collects what Stock Titan holds for CNNA, including price data, latest news, financial highlights, and short interest trends.
Stock Performance
CANN AMERICAN (CNNA) closed at $0.0048 on October 26, 2026. Over the past 12 months, the price has gained 92.0%.
CNNA Metrics & Rankings
Price returns through October 26, 2026. Month-to-date and YTD include the first trading day. Ranking links may use different dates.
Latest News
CANN AMERICAN has 10 recent news articles. Of the recent coverage, 2 articles coincided with positive price movement and 6 with negative movement. Key topics include acquisition. View all CNNA news →
SEC Filings
Financial Highlights
operating income reached -$1.7M, and net income was -$1.7M. Diluted earnings per share stood at $1000000.00. The company generated -$65K in operating cash flow. The current ratio was 0.00, measuring current assets divided by current liabilities.
Upcoming Events
Short Interest History
Short interest in CANN AMERICAN (CNNA) currently stands at 184.3 thousand shares, down 7.1% from the previous reporting period, representing 0.1% of the shares outstanding. Since December 2025, short interest has decreased by 12.2%.
Days to Cover History
Days to cover for CANN AMERICAN (CNNA) currently stands at 1.9 days, down 12.3% from the previous period. The ratio is the reported short interest divided by the average daily trading volume. Since December 2025, the figure has decreased by 28.9%. Across the settlements charted above, it has ranged from 1.0 to 1000.0 days.
CNNA Company Profile & Sector Positioning
CANN AMERICAN (CNNA) operates in the Drug Manufacturers - Specialty & Generic industry within the broader Healthcare sector and is listed on the OTC.
Investors comparing CNNA often look at related companies in the same sector, including PLANET BSED FD GBL VT (PBFFF), PHARMADRUG INC (LMLLF), PETROS PHARM INC (PTPI), PREMIER BIOMEDICAL INC (BIEI), and KAYA HOLDINGS INC (KAYS). Comparing financial metrics, valuation ratios, and stock performance across these peers can help investors evaluate CNNA's relative position within its industry.